Development and Internal Validation of a Novel Nomogram Predicting the Outcome of Salvage Radiation Therapy for Biochemical Recurrence after Radical Prostatectomy in Patients without Metastases on Restaging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography
-
Published:2024-03
Issue:
Volume:61
Page:37-43
-
ISSN:2666-1683
-
Container-title:European Urology Open Science
-
language:en
-
Short-container-title:European Urology Open Science
Author:
Meijer DennieORCID,
van Leeuwen Pim J.,
Eppinga Wietse S.C.,
Vanneste Ben G.L.,
Meijnen Philip,
Daniels Laurien A.,
van den Bergh Roderick C.N.,
Lont Anne P.,
Bodar Yves J.L.,
Ettema Rosemarijn H.,
de Bie Katelijne C.C.,
Oudshoorn Frederik H.K.,
Nieuwenhuijzen Jakko A.,
van der Poel Henk G.,
Donswijk Maarten L.,
Heymans Martijn W.,
Oprea-Lager Daniela E.,
Schaake Eva E.,
Vis André N.
Reference31 articles.
1. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer;Han;J Urol,2003
2. Biochemical recurrence after radical prostatectomy: what does it mean?;Tourinho-Barbosa;Int Braz J Urol,2018
3. Cancer control with radical prostatectomy alone in 1,000 consecutive patients;Hull;J Urol,2002
4. Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial;Kneebone;Lancet Oncol,2020
5. Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial;Parker;Lancet,2020